ISSN: 2476-2075

Optometry: Open Access
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • Optom Open Access 2023, Vol 8(3): 196
  • DOI: 10.4172/2476-2075.1000196

Ocular Toxicity and Management Strategies in Uveal Melanoma Radiotherapy

Bulotta Rosa*
Department of Ophthalmology, University of Medicine and Pharmacy Carol Davila, Romania
*Corresponding Author : Bulotta Rosa, Department of Ophthalmology, University of Medicine and Pharmacy Carol Davila, Romania

Received Date: May 02, 2023 / Published Date: May 30, 2023

Abstract

Uveal melanoma is the most common primary intraocular malignancy, primarily affecting the choroid, ciliary body, and iris. Radiotherapy is an important treatment modality for preserving vision and preventing metastasis in patients with uveal melanoma. However, despite its efficacy, radiotherapy is associated with a range of ocular complications that can significantly impact visual function and quality of life. This article provides a comprehensive review of the ocular complications of radiotherapy in uveal melanoma, including radiation retinopathy, cataract formation, neovascular glaucoma, optic neuropathy, and radiation-induced tumor recurrence. The underlying mechanisms, clinical manifestations, diagnostic approaches, and management strategies for these complications are discussed, highlighting the importance of multidisciplinary care and long-term follow-up to optimize patient outcomes. A poor visual outcome is mainly associated with the presence of radiation retinopathy and radiation optic neuropathy. Therapeutic options are available for the majority of complications with the notable exception of optic neuropathy. Reducing complication rates can be achieved by lowering the dose of radiation, with the use of eccentric, customized plaques and careful planning of the irradiation delivery in order to protect structures vital to vision and by associating radiation therapy with other methods with the aim of reducing tumor volume.

Citation: Rosa B (2023) Ocular Toxicity and Management Strategies in Uveal Melanoma Radiotherapy. Optom Open Access 8: 196. Doi: 10.4172/2476-2075.1000196

Copyright: © 2023 Rosa B. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top